Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-22-038529)

Filing Details

Accession Number:: 0000899243-22-038529
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-12-14 21:22:15
Reporting Period:: 2022-12-14

Accepted Time:: 2022-12-14 21:22:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1796129	Vincerx Pharma Inc.	VINC	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1458506	Md Ahmed Hamdy	260 Sheridan Avenue, Suite 400 Palo Alto CA 94306	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-12-14	35,280	$0.87	73,760	No	4	P	Indirect	The Hamdy Family Trust dated 10/7/2015

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	The Hamdy Family Trust dated 10/7/2015

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,618,199	Direct

Footnotes

Represents a weighted average purchase price. Actual purchase prices ranged from $0.829 to $0.87 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares purchased within the range indicated.